| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/26/2006 | US7112560 Angiogenically effective unit dose of FGF-2 and method of use |
| 09/26/2006 | US7112427 Protein comprising mitogenic kinase activity for identifying modulators of inflammation, apoptosis and cell proliferation; antiproliferative agents |
| 09/26/2006 | US7112339 Compositions for controlled release of a biologically active agent, and the preparation thereof |
| 09/26/2006 | CA2330686C Process for making 1,3-disubstituted-4-oxocyclic ureas |
| 09/26/2006 | CA2254953C Therapies for chronic renal failure |
| 09/21/2006 | WO2006099204A1 Substituted 9-alkyladenines and the use thereof |
| 09/21/2006 | WO2006098519A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof |
| 09/21/2006 | WO2006098394A1 Method for inhibiting lipid absorption and lipid absorption inhibitor |
| 09/21/2006 | WO2006098304A1 Novel secretory protein derived from pituitary cell and use of the same |
| 09/21/2006 | WO2006097625A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/21/2006 | WO2006097459A1 Method for preventing cardiovascular diseases |
| 09/21/2006 | WO2006097273A1 Compounds having immunomodulator activity |
| 09/21/2006 | WO2006097260A1 Adenosine derivatives having a2a receptor activity |
| 09/21/2006 | WO2006097169A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 09/21/2006 | WO2006097090A1 Retinol for reducing risk factors of arteriosclerosis and/or increasing insulin sensitivity |
| 09/21/2006 | WO2006079077A3 Use of diltiazem or analogs thereof as modulators of ghrelin receptor |
| 09/21/2006 | WO2006055573A3 Methods of using pde v inhibitors for the treatment of congestive heart failure |
| 09/21/2006 | WO2005112897A3 Immediate release pharmaceutical tablets with height greater than width |
| 09/21/2006 | WO2004089282A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2006 | US20060212109 Delivery of therapeutic capable agents |
| 09/21/2006 | US20060211860 Compounds for the treatment of Alzheimer's disease |
| 09/21/2006 | US20060211764 Cell activator, process for producing cell activator and apparatus therefor |
| 09/21/2006 | US20060211719 Heteroaryl aminoguanidine and alkoxyguanidines and their use as protease inhibitors |
| 09/21/2006 | US20060211717 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/21/2006 | US20060211707 Piperazine-alkyl-ureido derivatives |
| 09/21/2006 | US20060211696 IMIDAZO[1,2-b]PYRIDAZINE COMPOUND |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211680 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis |
| 09/21/2006 | US20060211674 Combination comprising a vasculostatic compound and an alkylating agent for the treatment of a tumor |
| 09/21/2006 | US20060211664 Method for treating erectile dysfunction and increasing libido in men |
| 09/21/2006 | US20060211654 Pharmaceutical Compositions of Cholesteryl Ester Transfer Protein Inhibitor |
| 09/21/2006 | US20060211651 Persulfated oligosaccharide acting on selectins and chemokine |
| 09/21/2006 | US20060211618 Polynucleotides and polypeptides of the erythropoietin gene |
| 09/21/2006 | US20060211609 Novel agent for improving neurotransmission failure |
| 09/21/2006 | US20060211607 Somatostatin-dopamine chimeric analogs |
| 09/21/2006 | US20060211602 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/21/2006 | US20060211150 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211149 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211143 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211142 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060210647 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 09/21/2006 | US20060210635 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof |
| 09/21/2006 | US20060210550 Angiogenesis inducer |
| 09/21/2006 | US20060210535 Means for regulating the expression of human isoforms of ant |
| 09/21/2006 | DE102005012831A1 Herstellung eines Arzneimittels zur Senkung des Risikofaktors der Artherosklerose und/oder Erhöhung der Insulinsensitivität Manufacture of a medicament for reducing the risk factor of atherosclerosis and / or increasing insulin sensitivity |
| 09/21/2006 | DE102005012681A1 New 1,5-dihydro-pyrrol-2-one compounds are HDM2 inhibitors, useful for treating e.g. stroke, heart infarct, ischemia, multiple sclerosis, Alzheimer's disease, degenerative disease, viral infection and cancer |
| 09/21/2006 | CA2601717A1 Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof |
| 09/21/2006 | CA2601227A1 Mecano growth factor peptides and their use |
| 09/21/2006 | CA2601032A1 Substituted 9-alkyladenines and the use thereof |
| 09/21/2006 | CA2600904A1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 09/21/2006 | CA2600822A1 Method for preventing cardiovascular diseases |
| 09/21/2006 | CA2599643A1 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/21/2006 | CA2598865A1 Adenosine derivatives having a2a receptor activity |
| 09/20/2006 | EP1702926A1 Levulose glucoselipid a analogue |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1702625A1 Medicine containing genetically modified antibody against chemokine receptor ccr4 |
| 09/20/2006 | EP1702623A2 Use of interferon gamma for the treatment of cardiac hypertrophy |
| 09/20/2006 | EP1702617A1 Cannabimimetic indole derivatives |
| 09/20/2006 | EP1701953A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 09/20/2006 | EP1701951A2 Modulators of peripheral 5-ht receptors |
| 09/20/2006 | EP1701943A1 5-ht2 receptors modulators, their pharmaceutical compositions and their use for the treatment of cardiovascular and muscle diseases |
| 09/20/2006 | EP1701933A1 Novel compounds |
| 09/20/2006 | EP1701717A1 Method of treating elevated plasma homocysteine levels in esrd patients |
| 09/20/2006 | EP1701701A1 Methods of preparing a foam comprising a sclerosing agent |
| 09/20/2006 | EP1554253A4 Imidazolium cxcr3 inhibitors |
| 09/20/2006 | EP1397148B1 Chromium/biotin treatment of dyslipidemia |
| 09/20/2006 | EP1368364B1 C2, 8-disubstituted adenosine derivatives and their different uses |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1276491B1 Tamandarin and didemnin analogs and methods of making and using them |
| 09/20/2006 | EP1218049B1 Apparatus for relieving headaches, rhinitis and other common ailments |
| 09/20/2006 | EP1161944B1 Drugs, foods and oral compositions containing stilbene-type compounds |
| 09/20/2006 | EP0923582B1 Substituted 6,5-hetero-bicyclic derivatives |
| 09/20/2006 | CN1835969A Mechanism of conditional regulation of hypoxia-inducible factor-1 by von Hippel-Lindau tumor suppressor protein |
| 09/20/2006 | CN1835952A Compounds and compositions as inhibitors of receptor tyrosine kinase activity |
| 09/20/2006 | CN1835950A Imidazopyridine derivatives |
| 09/20/2006 | CN1835926A Process for the preparation of nonpeptide substituded spirobenzoazepine derivatives |
| 09/20/2006 | CN1835925A Substituted spirobenzazepines |
| 09/20/2006 | CN1834238A Prepn. process of and use of thrombus dissolving enzyme |
| 09/20/2006 | CN1833711A Medicine for treating apoplectic sequel and prepn. thereof |
| 09/20/2006 | CN1833709A Honey capsule |
| 09/20/2006 | CN1833708A Capsule for treating hypertension |
| 09/20/2006 | CN1833699A Quickly-acting antithrombotic and hemostatic medicine |
| 09/20/2006 | CN1833686A Pure Chinese medicinal hypotensor |
| 09/20/2006 | CN1833684A Film cladded tablet for treating coronary heart disease |
| 09/20/2006 | CN1833677A Chinese medicinal injection and its prepn. method |
| 09/20/2006 | CN1833676A Danlan pain relieving oral preparation |
| 09/20/2006 | CN1833672A Chinese medicinal honey bolus for treating apoplexia sequel and its mfg. method |
| 09/20/2006 | CN1833668A Medicinal compsns. having cooperative action |
| 09/20/2006 | CN1833665A Mangosteen peel extracts, its extraction method and medicine use |
| 09/20/2006 | CN1833664A Pterigospermin capsules and prodn. method |
| 09/20/2006 | CN1833663A Sustained release capsules of ginkgo leaf and prepn. method |
| 09/20/2006 | CN1833658A Medicine for treatment of cardio-cerebral blood vessel diseases and diabetes, and its prepn. method |
| 09/20/2006 | CN1833656A Cyclic AMP injecta and its prepn. process |
| 09/20/2006 | CN1833653A Application and prepn. process of shiyacha total flavone |
| 09/20/2006 | CN1833651A Xindakang drip pill and prepn. thereof |
| 09/20/2006 | CN1833646A Active substance of oxidized low density lipoprotein derivative for treating arterial thrombus form |
| 09/20/2006 | CN1833645A Huangyangning dispersion tablets and prepn. process |
| 09/20/2006 | CN1833639A 'Xindakang' dispersion tablets and prepn. method |
| 09/20/2006 | CN1276084C Long-noded pit viper poison dissolving fiber protein No.8 gene and use thereof |
| 09/20/2006 | CN1275979C Carboline carboxylic acid contaiing P6A associated sequence and synthesis and medical application thereof |